2025. RIGHT TO HEALTH AND THE PROVISION OF HIGH-COST AND UNREGISTERED MEDICATIONS BY ANVISA. ERR01. 10, 4 (Sep. 2025), e8426. DOI:https://doi.org/10.56238/ERR01v10n4-033.